SIX:SANN
Santhera Pharmaceuticals Holding AG · SIX · Healthcare · CHF · FY for 2025
Figures on this page computed 2026-11-08 12:56 UTC
Last close
n/aCHF
Market data
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-63.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
-45.1%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- computed
Safety is the furthest below its sector's middle: 0.22 against 0.52 on the market's range.
- Growth38.8%64 of 100, above its sector
- Returns on capital-33.3%17 of 100, below its sector
- Margins18.7%19 of 100, below its sector
- Price2.5x42 of 100, above its sector
- Safety1.2922 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
All from 100
lens 2 of 9Sales
1,786Profit
-828Shares in issue
2,373Sales is at 1786, Profit is at -828, Shares in issue is at 2373, against 100 in 2015.
Sales is at 1786, Profit is at -828, Shares in issue is at 2373, against 100 in 2015.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales, where the first year is 1001,786
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CHF
Profit, where the first year is 100-828
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CHF
Shares in issue, where the first year is 1002,373
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CHF